Long-acting GHRH analogue for research in growth hormone and IGF-1 secretion.
PURITY
DISPATCH
VERIFIED
Description
CJC-1295 with DAC is a long-acting synthetic analogue of growth hormone–releasing hormone (GHRH). The Drug Affinity Complex (DAC) modification extends the compound's circulation time by enabling prolonged interaction with albumin. In controlled human studies, CJC-1295 produced sustained increases in circulating growth hormone (GH) and IGF-1; the reported half-life was approximately 5.8–8.1 days. Human research has primarily evaluated its pharmacokinetics and effects on GH/IGF-1, rather than establishing clinical benefits such as muscle growth, fat loss, improved recovery, or enhanced performance.
Common Use — Research
For a research-use-only catalog, CJC-1295 with DAC is commonly used to investigate:
Purity: ≥99%
Verified: Third-party tested